Analysis: Why Health Care Reformers Are Wooing Skeptical Seniors
The over-65 crowd, with its outsized political clout, will have a big say in the fate of any health overhaul. And that helps explain a recent agreement on drug discounts involving the pharmaceutical industry, the White House and Congress.
